Literature DB >> 27649701

Identification of a Novel Deletion Mutation (c.1780delG) and a Novel Splice-Site Mutation (c.1412-1G>A) in the CCM1/KRIT1 Gene Associated with Familial Cerebral Cavernous Malformation in the Chinese Population.

Chenlong Yang1,2, Jizong Zhao1,2, Bingquan Wu3, Haohao Zhong3, Yan Li3, Yulun Xu4,5.   

Abstract

Cerebral cavernous malformation (CCM) is a congenital vascular anomaly predominantly located within the central nervous system. Its familial forms (familial cerebral cavernous malformation (FCCM)), inherited in an autosomal dominant manner with incomplete penetrance, are attributed to mutations in CCM1/KRIT1, CCM2/MGC4607, and CCM3/PDCD10 genes. To date, little is known about the genetic alterations leading to FCCM in the Chinese population. We aimed to investigate the genetic defect of FCCM by DNA sequencing in Chinese families. This study enrolled five Chinese families with FCCM. All index cases underwent surgical treatment and were diagnosed with CCM by pathology; their relatives were diagnosed based on radiological and/or pathological evidence. Genomic DNA was extracted from peripheral blood and amplified using polymerase chain reaction (PCR) for DNA sequencing. The five families comprised a total of 21 affected individuals: 12 of these were symptomatic, and 9 were asymptomatic. Sequence analyses in the index patients disclosed three heterozygous loss-of-function mutations in the CCM1/KRIT1 gene in three families, respectively: a novel deletion mutation (c.1780delG; p.Ala594HisfsX67) in exon 16, a novel splice-site mutation (c.1412-1G>A) in the splice acceptor site in intron 13, and a previously described 4-bp deletion (c.1197_1200delCAAA; p.Gln401ThrfsX10) in exon 12. All of these mutations are predicted to cause a premature termination codon to generate a truncated Krev interaction trapped 1 (Krit1) protein. These mutations segregated in affected relatives. Our findings provided new CCM1 gene mutation profiles, which help to elucidate the pathogenesis of FCCM and will be of great significance in genetic counseling.

Entities:  

Keywords:  CCM1; DNA sequencing; Deletion mutation; Familial cerebral cavernous malformation; Novel mutation; Splice-site mutation

Mesh:

Substances:

Year:  2016        PMID: 27649701     DOI: 10.1007/s12031-016-0836-2

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  25 in total

1.  The value of susceptibility weighted magnetic resonance imaging in evaluation of patients with familial cerebral cavernous angioma.

Authors:  Haci Taner Bulut; Mehmet Akif Sarica; Ali Haydar Baykan
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  Cerebral cavernous malformations. Incidence and familial occurrence.

Authors:  D Rigamonti; M N Hadley; B P Drayer; P C Johnson; K Hoenig-Rigamonti; J T Knight; R F Spetzler
Journal:  N Engl J Med       Date:  1988-08-11       Impact factor: 91.245

3.  A gene responsible for cavernous malformations of the brain maps to chromosome 7q.

Authors:  J Dubovsky; J M Zabramski; J Kurth; R F Spetzler; S S Rich; H T Orr; J L Weber
Journal:  Hum Mol Genet       Date:  1995-03       Impact factor: 6.150

4.  Cerebral cavernous malformation: novel mutation in a Chinese family and evidence for heterogeneity.

Authors:  Dong-Hui Chen; Hillary P Lipe; Zhen Qin; Thomas D Bird
Journal:  J Neurol Sci       Date:  2002-04-15       Impact factor: 3.181

5.  Familial cerebral cavernomas due to a KRIT1 mutation presenting with epilepsy.

Authors:  Sanjeev Rajakulendran; Sreeman Andole; Angus Kennedy
Journal:  BMJ Case Rep       Date:  2011-03-24

6.  Deletions in CCM2 are a common cause of cerebral cavernous malformations.

Authors:  Christina L Liquori; Michel J Berg; Ferdinando Squitieri; Tracey P Leedom; Louis Ptacek; Eric W Johnson; Douglas A Marchuk
Journal:  Am J Hum Genet       Date:  2006-11-14       Impact factor: 11.025

7.  CCM molecular screening in a diagnosis context: novel unclassified variants leading to abnormal splicing and importance of large deletions.

Authors:  Florence Riant; Michaelle Cecillon; Pascale Saugier-Veber; Elisabeth Tournier-Lasserve
Journal:  Neurogenetics       Date:  2013-04-18       Impact factor: 2.660

Review 8.  Recent insights into cerebral cavernous malformations: the molecular genetics of CCM.

Authors:  Florence Riant; Francoise Bergametti; Xavier Ayrignac; Gwenola Boulday; Elisabeth Tournier-Lasserve
Journal:  FEBS J       Date:  2010-01-22       Impact factor: 5.542

9.  Multilocus linkage identifies two new loci for a mendelian form of stroke, cerebral cavernous malformation, at 7p15-13 and 3q25.2-27.

Authors:  H D Craig; M Günel; O Cepeda; E W Johnson; L Ptacek; G K Steinberg; C S Ogilvy; M J Berg; S C Crawford; R M Scott; E Steichen-Gersdorf; R Sabroe; C T Kennedy; G Mettler; M J Beis; A Fryer; I A Awad; R P Lifton
Journal:  Hum Mol Genet       Date:  1998-11       Impact factor: 6.150

10.  Mutation prevalence of cerebral cavernous malformation genes in Spanish patients.

Authors:  Rufino Mondéjar; Francisca Solano; Rocío Rubio; Mercedes Delgado; Angel Pérez-Sempere; Antonio González-Meneses; Teresa Vendrell; Guillermo Izquierdo; Amalia Martinez-Mir; Miguel Lucas
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

View more
  7 in total

1.  A Novel KRIT1/CCM1 Gene Insertion Mutation Associated with Cerebral Cavernous Malformations in a Chinese Family.

Authors:  Hui Wang; Yunzhu Pan; Zaiqiang Zhang; Xingang Li; Zhe Xu; Yue Suo; Wei Li; Yongjun Wang
Journal:  J Mol Neurosci       Date:  2017-02-03       Impact factor: 3.444

2.  A Novel CCM1/KRIT1 Heterozygous Nonsense Mutation (c.1864C>T) Associated with Familial Cerebral Cavernous Malformation: a Genetic Insight from an 8-Year Continuous Observational Study.

Authors:  Chenlong Yang; Van Halm-Lutterodt Nicholas; Jizong Zhao; Bingquan Wu; Haohao Zhong; Yan Li; Yulun Xu
Journal:  J Mol Neurosci       Date:  2017-03-02       Impact factor: 3.444

3.  Identification of a novel LATS1 variant associated with familial cerebral cavernous malformations in a Chinese family.

Authors:  Liangyuan Geng; Tao Jiang; Yihao Zhu; Qingru Wang; Wenwen Yuan; Xinhua Hu; Yuanjie Zou; Hong Xiao; Hongyi Liu
Journal:  Neurol Sci       Date:  2022-08-19       Impact factor: 3.830

4.  Two Novel CCM2 Heterozygous Mutations Associated with Cerebral Cavernous Malformation in a Chinese Family.

Authors:  Qin Du; Ziyan Shi; Hongxi Chen; Ying Zhang; Jiancheng Wang; Hongyu Zhou
Journal:  J Mol Neurosci       Date:  2019-01-30       Impact factor: 3.444

5.  CCM1 and CCM2 variants in patients with cerebral cavernous malformation in an ethnically Chinese population in Taiwan.

Authors:  Chun-Wei Chang; Peng-Wei Hsu; Kuo-Chen Wei; Chia-Wen Chang; Hon-Chung Fung; Mo-Song Hsih; Wen-Chuin Hsu; Long-Sun Ro; Chen-Nen Chang; Jiun-Jie Wang; Yih-Ru Wu; Sien-Tsong Chen
Journal:  Sci Rep       Date:  2019-08-27       Impact factor: 4.379

6.  KRIT1 Gene in Patients with Cerebral Cavernous Malformations: Clinical Features and Molecular Characterization of Novel Variants.

Authors:  Claudia Ricci; Alfonso Cerase; Giulia Riolo; Giuditta Manasse; Stefania Battistini
Journal:  J Mol Neurosci       Date:  2021-03-02       Impact factor: 3.444

7.  Genetic syndromes with vascular malformations - update on molecular background and diagnostics.

Authors:  Adam Ustaszewski; Joanna Janowska-Głowacka; Katarzyna Wołyńska; Anna Pietrzak; Magdalena Badura-Stronka
Journal:  Arch Med Sci       Date:  2020-02-25       Impact factor: 3.318

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.